NO751303L - - Google Patents
Info
- Publication number
- NO751303L NO751303L NO751303A NO751303A NO751303L NO 751303 L NO751303 L NO 751303L NO 751303 A NO751303 A NO 751303A NO 751303 A NO751303 A NO 751303A NO 751303 L NO751303 L NO 751303L
- Authority
- NO
- Norway
- Prior art keywords
- virus
- cells
- cell line
- medium
- liver
- Prior art date
Links
- 210000004185 liver Anatomy 0.000 claims description 13
- 239000002609 medium Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 210000000981 epithelium Anatomy 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 4
- 239000012888 bovine serum Substances 0.000 claims description 3
- 244000309466 calf Species 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 239000007640 basal medium Substances 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 44
- 241000700605 Viruses Species 0.000 description 25
- 210000005229 liver cell Anatomy 0.000 description 7
- 229920002527 Glycogen Polymers 0.000 description 5
- 229940096919 glycogen Drugs 0.000 description 5
- 210000003494 hepatocyte Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241000700618 Vaccinia virus Species 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 241000701161 unidentified adenovirus Species 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- 208000004232 Enteritis Diseases 0.000 description 2
- 241000272184 Falconiformes Species 0.000 description 2
- 241000282324 Felis Species 0.000 description 2
- 208000000474 Poliomyelitis Diseases 0.000 description 2
- 241000710961 Semliki Forest virus Species 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000013256 coordination polymer Substances 0.000 description 2
- 230000000120 cytopathologic effect Effects 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229940031551 inactivated vaccine Drugs 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 241001529453 unidentified herpesvirus Species 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- 241001466953 Echovirus Species 0.000 description 1
- 241001492220 Echovirus E2 Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000282555 Erythrocebus patas Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000701190 Human adenovirus 11 Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000711408 Murine respirovirus Species 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 241000710960 Sindbis virus Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 210000001840 diploid cell Anatomy 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000003917 human chromosome Anatomy 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000007758 minimum essential medium Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000590 oncogenic Toxicity 0.000 description 1
- 230000002246 oncogenic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3360569 | 1969-07-03 | ||
| GB3997369 | 1969-08-11 | ||
| NO262170 | 1970-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO751303L true NO751303L (uk) | 1971-01-05 |
Family
ID=27259146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO751303A NO751303L (uk) | 1969-07-03 | 1975-04-14 |
Country Status (1)
| Country | Link |
|---|---|
| NO (1) | NO751303L (uk) |
-
1975
- 1975-04-14 NO NO751303A patent/NO751303L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hopps et al. | Biologic characteristics of a continuous kidney cell line derived from the African green monkey | |
| CN1228119B (zh) | 用于病毒生长的固定化细胞系 | |
| Wong et al. | Changing viral susceptibility of a human cell line in continuous cultivation: I. Production of infective virus in a variant of the Chang conjunctival cell following infection with swine or N-WS influenza viruses | |
| Van Hemert et al. | Homogeneous cultivation of animal cells for the production of virus and virus products | |
| Jeon et al. | Unusual intra-cellular bacterial infection in large, free-living amoebae | |
| Hunter | [32] Biological techniques for avian sarcoma viruses | |
| JP2633392B2 (ja) | ウイルス／ウイルス抗原を生産するためのバイオマス | |
| US3935066A (en) | Cell lines | |
| US3887430A (en) | Culture medium for tissue culture techniques | |
| Pudney et al. | Anopheles stephensi var. mysorensis: Establishment of a larval cell line (Mos. 43) | |
| Morgan et al. | Latent viral infection of cells in tissue culture: IV. Latent infection of L cells with psittacosis virus | |
| RU2082757C1 (ru) | Субстрат для культивирования флавивирусов или ареновирусов на основе культуры клеток и способ получения антигена флавивируса или ареновируса | |
| Sharpless et al. | GAL virus: its growth cycle in tissue culture and some of its properties | |
| US5719051A (en) | Perfusion system and a method for the large scale production of virus or virus antigen | |
| JP4478328B2 (ja) | 生化学的薬剤の生産のための細胞の調製 | |
| CN109402068A (zh) | 一种制备无血清残留的猪伪狂犬病毒的方法 | |
| NO751303L (uk) | ||
| JPH0998778A (ja) | マレク病ワクチン | |
| CN106801031A (zh) | 无成瘤性mdck细胞克隆株 | |
| US3228840A (en) | Virus culture | |
| US4112068A (en) | Canine lung cell strain culture systems and processes for the cultivation of viruses and vaccines therefrom | |
| WO1985005375A1 (en) | Methods for culturing diploid cells on cellulose fibers | |
| US3432595A (en) | Melanoma cell line of canine origin,its propagation and use,and vaccines derived therefrom | |
| RU2306334C2 (ru) | МЕЖВИДОВАЯ ЛИНИЯ ГИБРИДНЫХ КЛЕТОК ПОЧКИ ОВЦЫ (Ovis aries) С ЛИМФОЦИТАМИ КРОЛИКА (ПО-TK-×ЛК) ДЛЯ КУЛЬТИВИРОВАНИЯ ВИРУСОВ ИНФЕКЦИОННОГО РИНОТРАХЕИТА И ВИРУСНОЙ ДИАРЕИ - БОЛЕЗНИ СЛИЗИСТЫХ КРУПНОГО РОГАТОГО СКОТА | |
| Randall et al. | Cultivation of Yeast in Earle's “L” Strain Mouse Cells in vitro. |